12:00 AM
 | 
Feb 25, 2002
 |  BioCentury  |  Tools & Techniques

Bypassing the opioid system

For years, a glance at any list of pain products in development has been disappointing, as most have been merely variations on the opioid theme. But a newly discovered subclass of G protein-coupled receptors (GPCRs) may prove to be highly specific non-opioid targets to treat pain and other sensory neuron-related indications.

Scientists from AstraZeneca plc (LSE:AZN; AZN, London, U.K.) spotted the first evidence of the subclass when they found a 650 base pair cDNA fragment during a search for...

Read the full 382 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >